Novo Nordisk: Intense Competition Within The GLP-1 Duopoly Summary Novo Nordisk reached an all-time high of $148.15 in June 2024, when market participants were widely optimistic about the prospects of NVO's new semaglutide drug for weight management, Wegovy
However, strength training is even more effective when combined with regular use of cystine-rich native whey protein isolate (3)
Sublingual formulations: Sublingual GLP-1 preparations typically need refrigeration, though some stable formulations may allow short-term room temperature storage
There are, however, simple economics of drug development processes that make it so BPC-157 likely will never go through the full process of drug approval because of financial incentives
What we monitor: Fasting glucose and insulin sensitivity markers are tracked before, during, and after your cycle